Baxter (BAX) Misses Q4 EPS by 10c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts BAX Hot Sheet
Price: $26.73 -1.18%
Financial Fact:
Research and development expenses: 159M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development expenses: 159M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Baxter (NYSE: BAX) reported Q4 EPS of $0.44, $0.10 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $2.97 billion versus the consensus estimate of $2.84 billion.
GUIDANCE:
Baxter sees FY2026 EPS of $1.85-$2.05, versus the consensus of $2.25.
For earnings history and earnings-related data on Baxter (BAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
